메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한암학회 Cancer Research and Treatment Cancer Research and Treatment 제46권 제1호
발행연도
2014.1
수록면
55 - 64 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
PurposeThe novel heat shock protein tumor necrosis factor receptor-associated protein 1(TRAP1) is associated with multidrug resistance in colorectal cancer (CRC) cells invitro. Excision repair cross-complementation group 1 (ERCC1) expression levels intumor tissues also predict clinical outcomes in metastatic CRC patients receivingcombination oxaliplatin and 5-fluorouracil treatment. We investigated whether TRAP1and ERCC1 protein expression by immunohistochemistry predict clinical outcomes inCRC patients. Materials and MethodsThe study population consisted of 56 patients with metastatic CRC who receivedfirst-line oxaliplatin/5-fluorouracil therapy. Clinical response and overall survival (OS)by levels of the markers TRAP1 and ERCC1 were evaluated. ResultsThe rates of TRAP1 and ERCC1 expression were 21% and 52%, respectively. Patientsnegative for ERCC1 expression showed a tendency to respond to chemotherapy(p=0.066). Median OS was significantly longer in patients negative for TRAP1 thanthose positive for TRAP1 (p=0.023). Patients negative for ERCC1 expression also hada better OS than those positive for ERCC1 (p=0.021). The median OS was 30.9months for patients negative for TRAP1 and ERCC1 compared to 13.2 months forthose positive for TRAP1 and/or positive for ERCC1 expression (p=0.006). Thecombination of TRAP1 and ERCC1 expression was significantly associated with theresponse to chemotherapy (p=0.046) and independently predicted median OS inmultivariate analysis (hazard ratio, 2.98; 95% confidence interval, 1.18 to 7.49). ConclusionThe present study demonstrates that the combination of TRAP1 and ERCC1 expressionpredicts the survival of metastatic CRC patients who were treated with oxaliplatin/5-fluorouracil.

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0